Depressive syndromes in schizophrenia

The Overlap of Affective and Schizophrenic Spectra

Volumn 9780521858588, Issue , 2006, Pages 156-181

  Gaebel, Wolfgang ^a   Bittner, Ellen ^a   Wölwer, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS;

DEPRESSIVE SYMPTOM; DIFFERENTIAL DIAGNOSIS; LONGITUDINAL COURSE; NEW TECHNOLOGIES; SIDE EFFECT;

DISEASES;

EID: 39649101421     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544040.010     Document Type: Chapter

References (74)

1. Addington, D., Addington, J., Maticka-Tyndale, E. and Joyce, J. (1992). Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research. 6, 201–8.
2. Addington, D., Azorin, J. M., Falloon, I. R. et al. (2002). Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatrica Scandinavica. 105, 189–95.
3. American Psychiatric Association (1994): DSM-IV: Diagnostic and Statistical Manual of MentalDisorders. Washington, DC: APA.
4. Asherson, P., Mant, R., Williams, N. et al. (1998). A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Molecular Psychiatry. 3, 310–20.
5. Baynes, D., Mulholland, C., Cooper, S. J. et al. (2000). Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophrenia Research. 45, 47–56.
6. Bench, C. J., Friston, K. J., Brown, R. G. et al. (1992). The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression. Psychological Medicine. 76, 89–93.
7. Benson, D. F. (1990). Behavioral aspects of movement disorders: Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 3, 1–2.
8. Berrios, G. E. and Bulbena, A. (1987). Post psychotic depression: the Fulbourn cohort. Acta Psychiatrica Scandinavica. 76, 89–93.
9. Bozikas, V. P., Kosmidis, M. H., Kioperlidou, K. and Karavatos, A. (2004). Relationship between psychopathology and cognitive functioning in schizophrenia. Comprehensive Psychiatry. 45, 392–400.
10. Brebion, G., Amador, X., Smith, M., Malaspina, D., Sharif, Z. and Gorman, J. M. (2000). Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 13, 177–83.
11. Brebion, G., Gorman, J. M., Malaspina, D., Sharif, Z. and Amador, X. (2001). Clinical and cognitive factors associated with memory task performance in patients with schizophrenia. American Journal of Psychiatry. 158, 58–764.
12. Brebion, G., Smith, M. J., Amador, X., Malaspina, D., and Gorman, J. M. (1997). Clinical correlates of memory in schizophrenia: differential links between depression, positive and negative symptoms, and two types of memory impairment. American Journal of Psychiatry. 154, 1538–43.
13. Bressan, R. A., Chaves, A. C., Pilowsky, L. S., Shirakawa, I. and Mari, J. J. (2003). Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Research. 117, 47–56.
14. Bressan, R. A., Costa, D. C., Jones, H. M., Ell, P. J. and Pilowsky, L. S. (2002). Typical antipsychotic drugs – D2 receptor occupancy and depressive symptoms in schizophrenia. Schizophrenia Research. 56, 31–6.
15. Cardno, A. G., Jones, L. A., Murphy, K. C., et al.(1998). Sibling pairs with schizophrenia or schizoaffective disorder: associations of subtypes, symptoms and demographic variables. Psychological Medicine. 28(4), 815–23.
16. Carson, W. H., Archibald, D. G., Manos, G., Kostic, D., Marcus, R. and Stock, E. G. (2003). Shortterm efficacy of aripiprazole on depression/anxiety in schizophrenia. Poster presentation. APA, San Francisco.
17. Davidson, R. J. and Irwin, W. (1999). The functional neuroanatomy of emotion and affective style. Trends in Cognitive Sciences. 3, 11–21.
18. Davidson, R. J., Pizzagalli, D., Nitschke, J. B. and Putnam, K. M. (2002). Depression: perspectives from neuroscience. Annual Review of Psychology. 53, 545–74.
19. Davidson, R. J., Putnam, K. M. and Larson, C. L. (2000). Dysfunction in the neural circuitry of emotion regulation: a possible prelude to violence. Science. 289, 591–4.
20. DeLisi, L. E., Goldin, L. R., Maxwell, M. E., Kazuba, D. M. and Gershon, E. S. (1987). Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Archives of General Psychiatry. 44(10), 891–6.
21. Dollfus, S., Ribeyre, J. M. and Petit, M. (2000). Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms. Psychopathology. 33, 125–30.
22. Ekman, P. and Friesen, W. V. (1978). Facial action coding system: a technique for the measurement of facial movement. Palo Alto: Consulting Psychologists Press.
23. El Yazaji, M., Battas, O., Agoub, M. et al.(2002). Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia. Schizophrenia Research. 56, 121–7.
24. Gaebel, W. and Wölwer, W. (1992). Facial expression and emotional face recognition in schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience. 242, 46–52.
25. Gaebel, W. and Wölwer, W. (1996). Affektstörungen Schizophren Kranker. Stuttgart: Kohlhammer.
26. Gaebel, W. and Wölwer, W. (2004). Facial expressivity in the course of schizophrenia and depression. European Archives of Psychiatry and Clinical Neuroscience. 254, 335–42.
27. Green, B. (2004). Focus on aripiprazole. Current Medical Research and Opinion. 20(2), 207–13.
28. Golimbet, V. E., Alfimova, M. V., Shchebatykh, T. V. et al. (2004). Serotonin transporter polymorphism and depressive-related symptoms in schizophrenia. American Journal of Medical Genetics. 126, 1–7.
29. Guze, S. B., Cloninger, C. R., Martin, R. L. and Clayton, P. J. (1983). A follow-up and family study of schizophrenia. Archives of General Psychiatry. 40, 1273–6.
30. Häfner, H., Riecher-Rössler, A., Hambrecht, Maurer. K., et al. (1992). IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research. 6, 209–23.
31. Hausmann, A. and Fleischhacker, W. W. (2002). Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatrica Scandinavica. 106, 83–96.
32. Hietala, J., Syvalahti, E., Vilkman, H. et al. (1999). Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophrenia Research. 35, 41–50.
33. Hill, S. K., Keshavan, M. S., Thase, M. E. and Sweeney, J. A. (2004). Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. American Journal of Psychiatry. 161, 996–1003.
34. Holthausen, E. A., Wiersma, D., Knegtering, R. H. and van den Bosch, R. J. (1999). Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. Schizophrenia Research. 23(39), 65–71.
35. Joiner, T. E., Brown, J. S. and Metalsky, G. I. (2003). A test of the tripartite model’s prediction of anhedonia’s specificity to depression: patients with major depression versus patients with schizophrenia. Psychiatry Research. 119, 243–50.
36. Kasanin, J. (1933). The acute schizoaffective psychoses. American Journal of Psychiatry. 90, 97–126.
37. Keck, P. Jr., Buffenstein, A., Ferguson, J. et al. (1998). Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Psychopharmacology. 140, 173–84.
38. Kendler, K. S., Myers, J. M., O’Neill, F. A. et al. (2000). Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish study of high-density schizophrenia families. American Journal of Psychiatry. 157, 402–8.
39. Kendler, K. S. and Hays, P. (1983). Schizophrenia subdivided by the family history of affective disorder. A comparison of symptomatology and course of illness. Archives of General Psychiatry. 40, 951–5.
40. Kendler, K. S., Karkowski-Shuman, L., O’Neill, F. A. et al. (1997). Resemblance of psychotic symptoms and syndromes in affected siblings pairs from the Irish study of high-density schizophrenia families: evidence for possible etiologic heterogeneity. American Journal of Psychiatry. 154, 191–8.
41. Kendler, K. S., Karkowski-Shuman, L. and Walsh, D. (1996). The risk for psychiatric illness in siblings of schizophrenics: the impact of psychotic and non-psychotic affective illness and alcoholism in parents. Acta Psychiatrica Scandinavica. 94, 49–55.
42. Kendler, K. S., McGuire, M., Gruenberg, A. M. et al. (1993). The Roscommon family study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry. 50, 527–40.
43. Kohler, C., Gur, R. C., Swanson, C. L., Petty, R. and Gur, R. E. (1998a). Depression in schizophrenia: I. Association with neuropsychological deficits. Biological Psychiatry. 43, 165–72.
44. Kohler, C., Swanson, C. L., Gur, R. C., Mozley, L. H. and Gur, R. E. (1998b). Depression in schizophrenia: II. MRI and PET findings. Biological Psychiatry. 42, 173–80.
45. Lancon, C., Auquier, P., Reine, G., Bernard, D. and Addington, D. (2001). Relationship between depression and psychotic symptoms of schizophrenia during an acute episode and stable period. Schizophrenia Research. 47, 135–40.
46. LeDoux, J. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience. 23, 155–84.
47. Leff, J. (1990). Depressive symptoms in the course of schizophrenia. In Depression in Schizophrenia, ed. L. E. DeLisi. Washington, DC: American Psychiatric Press, pp. 1–23.
48. Levinson, D. F., Umapathy, C. and Musthaq, M. (1999). Treatment of schizoaffective disorder and schizophrenia with mood symptoms. American Journal of Psychiatry. 156, 1138–48.
49. Maier, W., Lichtermann, D., Minges, J. et al. (1993). Continuity and discontinuity of affective disorders and schizophrenia: results of a controlled family study. Archives of General Psychiatry. 50, 871–83.
50. Mayberg, H. (2002). Depression, II: Localization of pathophysiology. American Journal of Psychiatry. 159, 1979.
51. Miller, E. K. and Cohen, J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience. 24, 167–202.
52. Müller, M. J. and Wetzel, H. (1998). Dimensionality of depression in acute schizophrenia: a methodological study using the Bech-Rafaelsen Melancholia Scale (BRMES). Journal of Psychiatric Research. 32, 369–78.
53. Müller, M. J., Wetzel, H. and Benkert, O. (2002). Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis. International ClinicalPsychopharmacology. 17, 249–61.
54. Müller, M. J., Szegedi, A., Wetzel, H. and Benkert, O. (2001). Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophrenia Bulletin. 27, 19–28.
55. Peralta, V. and Cuesta, M. J. (1999). Negative, parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited. Schizophrenia Research. 40, 245–53.
56. Peuskens, J., Möller H. J. and Puech, A. (2002). Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone. European Neuropsychopharmacology. 12, 305–10.
57. Peuskens, J., Van Baelen, B., De Smedt, C. and Lemmens, P. (2000). Effects of risperidone on affective symptoms in patients with schizophrenia. International Clinical Psychopharmacology. 15, 343–9.
58. Polzer, U. and Gaebel, W. (1993). Beeinflussen sich visuelle und auditive Wahrnehmung bei der psychopathologischen Beurteilung von Ausrucksmerkmalen psychiatrischer Patienten? Nervenarzt. 64, 193–8.
59. Salokangas, R. K., Cannon, T., Van Erp, T. et al. (2002). Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. British Journal of Psychiatry. 181, 58–65.
60. Sands, J. R. and Harrow, M. (1999). Depression during the longitudinal course of schizophrenia. Schizophrenia Bulletin. 25, 157–71.
61. Schneider, K. (1971). Clinical Psychopathology. Stuttgart: Georg Thieme.
62. Schneider, F., Weiss, U., Kessler, C. et al. (1998). Differential amygdala activation in schizophrenia during sadness. Schizophrenia Research. 34(3), 133–42.
63. Serretti, A., Lattuada, E., Catalano, M. and Smeraldi, E. (1999b). Serotonin transporter gene is not associated with symptomatology of schizophrenia. Schizophrenia Research. 35, 33–9.
64. Serretti, A., Lattuada, E., Cusin, C. et al. (1999c). Dopamine D3 receptor gene is not associated with symptomatology of major psychoses. American Journal of Medical Genetics. 88(5), 486–91.
65. Serretti, A., Lilli, R., Di Bella, D. et al. (1999a). No interaction between serotonin tranporter gene and dopamine receptor D4 gene in symptomatology of major psychoses. American Journal of Medical Genetics. 88(5), 481–5.
66. Siris, S. G. (2000). Depression in schizophrenia: perspective in the era of “atypical” antipsychotic agents. American Journal of Psychiatry. 157, 1379–89.
67. Siris, S. G. and Bench, C. (2003). Depression and schizophrenia, In Schizophrenia, ed. S. R. Hinsch and D. R. Weinberger. Oxford: Blackwell, pp. 142–67.
68. Siris, S. G., Addington, D., Azorin, J. M. et al. (2001). Depression in schizophrenia: recognition and management in the USA. Schizophrenia Research. 47, 185–97.
69. Smith, G. N., Lang, D. J., Kopala, L. C. et al. (2003). Developmental abnormalities of the hippocampus in first-episode schizophrenia. Biological Psychiatry. 53, 555–61.
70. Tollefson, G. D., Andersen, S. W. and Tran, P. V. (1999). The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biological Psychiatry. 46(3), 365–73.
71. Tollefson, G. D., Sanger, T. M., Beasley, C. M. and Tran, P. V. (1998). A double blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biological Psychiatry. 43(11), 803–10.
72. Voruganti, L. P. and Awad, A. G. (2004). Is neuroleptic dysphoria a variant of drug-induced extrapyramidal side effects? Canadian Journal of Psychiatry, 49, 285–9.
73. Wölwer, W., Streit, M., Polzer, U. and Gaebel, W. (1996). Facial affect recognition in the course of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 246, 165–70.
74. Zisook, S., McAdams, L. A., Kuck, J. et al. (1999). Depressive symptoms in schizophrenia. American Journal of Psychiatry. 156, 1736–42.